Copyright © Inderes 2011 - present. All rights reserved.
Log in to receive notifications.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

FluoGuide

38.3

 

SEK

 

-2.79 %

Less than 1K followers

FLUO

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Ownership
Investor consensus
Compare
-2.79%
-6.36%
-20.79%
-2.17%
+12.98%
-24.16%
-21.68%
-5.73%
+327.2%

FluoGuide is a Danish company active in medical technology. The company's business focus is found in research and development of treatments against various forms of cancer, with the greatest focus on the development of products that guide surgical interventions. The products bind to the cancer cells, which then light up and are intended to be used to precisely remove harmful tumors in the patient's tissue.

Read more
Market cap
521.65M SEK
Turnover
226.39K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
28.5
2025

Interim report Q1'25

28.8
2025

Interim report Q2'25

27.11
2025

Interim report Q3'25

All
Research
Webcasts
Press releases
ShowingAll content types
Press release4/15/2025, 8:28 AM

FluoGuide includes first patient in phase II trial of FG001 for head and neck cancer

FluoGuide
Regulatory press release3/27/2025, 2:50 PM

Minutes from Annual General Meeting in FluoGuide A/S

FluoGuide
Regulatory press release3/12/2025, 8:49 AM

Notice of Annual General Meeting in FluoGuide A/S

FluoGuide

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2/28/2025, 7:31 AM

Redeye: FluoGuide Q4 2024 - Edging closer to clinical results

FluoGuide
Regulatory press release2/27/2025, 6:03 AM

FluoGuide A/S publishes year-end and annual report for the fiscal year 2024

FluoGuide
Regulatory press release2/27/2025, 6:00 AM

FluoGuide A/S publishes interim report for the period January – December 2024

FluoGuide
Dagens aktienyheder 29/01: Føroya Banki, FluoGuide A/S, Curasight og Ascelia Pharma AB
Analyst Comment1/29/2025, 7:59 AM

Dagens aktienyheder 29/01: Føroya Banki, FluoGuide A/S, Curasight og Ascelia Pharma AB

Dagens aktienyheder med Føroya Banki, FluoGuide A/S, Curasight og Ascelia Pharma AB

Føroya BankiFluoGuideCurasightAscelia Pharma
Press release1/15/2025, 3:34 PM

FluoGuide A/S receives approval for phase II trial in head and neck cancer

FluoGuide
Press release11/27/2024, 3:05 PM

Redeye: Fluoguide Q3 2024 - Gearing up for high-impact catalysts in 2025e

FluoGuide
Regulatory press release11/27/2024, 6:00 AM

FluoGuide A/S publishes interim report for the period January – September 2024

FluoGuide
Press release11/19/2024, 12:43 PM

Publication of positive phase II clinical data for FG001 in patients with head and neck cancer

FluoGuide
Regulatory press release11/12/2024, 5:23 PM

FluoGuide A/S issue warrants to board member, CMO and CFO

FluoGuide
Press release10/21/2024, 2:13 PM

Roger Gunnarsson resigns as board member due to return to a full-time investment banking career, which precludes him from holding board position in FluoGuide

FluoGuide
Press release10/7/2024, 11:13 AM

FluoGuide A/S submits Clinical Trial Application for phase II trial in head and neck cancer

FluoGuide
Press release8/29/2024, 5:19 PM

Redeye: Fluoguide Q2 2024 - Following the plan

FluoGuide
Regulatory press release8/29/2024, 6:55 AM

FluoGuide A/S publishes interim report for the period January – June 2024

FluoGuide
Regulatory press release8/26/2024, 7:05 AM

FluoGuide appoints Jens Ellrich as Chief Medical Officer

FluoGuide
Regulatory press release6/18/2024, 9:12 PM

FluoGuide has completed a directed share issue to existing and new investors raising proceeds of SEK 60 million

FluoGuide
Regulatory press release6/18/2024, 3:31 PM

FluoGuide intends to carry out a directed share issue of approximately SEK 60 million

FluoGuide
Press release5/30/2024, 2:51 PM

Redeye: Fluoguide Q1 2024 - Preparing for next steps

FluoGuide
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team